Search Results - "Borruel, N"

Refine Results
  1. 1

    Colonisation by Faecalibacterium prausnitzii and maintenance of clinical remission in patients with ulcerative colitis by Varela, E., Manichanh, C., Gallart, M., Torrejón, A., Borruel, N., Casellas, F., Guarner, F., Antolin, M.

    Published in Alimentary pharmacology & therapeutics (01-07-2013)
    “…Summary Background Although incrimination of the intestinal microbiota in the pathogenesis of IBD is widely accepted, few data are available about the role of…”
    Get full text
    Journal Article
  2. 2

    Oral oligofructose‐enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin by CASELLAS, F., BORRUEL, N., TORREJÓN, A., VARELA, E., ANTOLIN, M., GUARNER, F., MALAGELADA, J.‐R.

    Published in Alimentary Pharmacology and Therapeutics (01-05-2007)
    “…Summary Background Inulin and oligofructose promote selective growth of saccharolytic bacteria with low inflammatory potential. Objective To test the effect of…”
    Get full text
    Journal Article
  3. 3

    Fungal and Bacterial Loads: Noninvasive Inflammatory Bowel Disease Biomarkers for the Clinical Setting by Sarrabayrouse, G, Elias, A, Yáñez, F, Mayorga, L, Varela, E, Bartoli, C, Casellas, F, Borruel, N, Herrera de Guise, C, Machiels, K, Vermeire, S, Manichanh, C

    Published in mSystems (23-03-2021)
    “…Microbiome sequence data have been used to characterize Crohn's disease (CD) and ulcerative colitis (UC). Based on these data, we have previously identified…”
    Get full text
    Journal Article
  4. 4

    Increased mucosal tumour necrosis factor α production in Crohn’s disease can be downregulated ex vivo by probiotic bacteria by Borruel, N, Carol, M, Casellas, F, Antolín, M, de Lara, F, Espín, E, Naval, J, Guarner, F, Malagelada, J R

    Published in Gut (01-11-2002)
    “…Background and aims: Tumour necrosis factor α (TNF-α) plays a key role in the pathogenesis of intestinal inflammation in Crohn’s disease. The effect of…”
    Get full text
    Journal Article
  5. 5

    Fungal and Bacterial Loads: Noninvasive Inflammatory Bowel Disease Biomarkers for the Clinical Setting by Sarrabayrouse, G., Elias, A., Yáñez, F., Mayorga, L., Varela, E., Bartoli, C., Casellas, F., Borruel, N., Herrera de Guise, C., Machiels, K., Vermeire, S., Manichanh, C.

    Published in mSystems (01-04-2021)
    “…Microbiome sequence data have been used to characterize Crohn's disease (CD) and ulcerative colitis (UC). Based on these data, we have previously identified…”
    Get full text
    Journal Article
  6. 6

    Cutoff values of the Inflammatory Bowel Disease Questionnaire to predict a normal health related quality of life by Huamán, J W, Casellas, F, Borruel, N, Peláez, A, Torrejón, A, Castells, I, Masachs, M, Varela, E, Guarner, F

    Published in Journal of Crohn's and colitis (01-12-2010)
    “…One of the objectives in the treatment of the inflammatory bowel disease (IBD) is improving the patient's quality of life. However, we do not dispose of…”
    Get full text
    Journal Article
  7. 7

    The opinion of patients with inflammatory bowel disease on healthcare received by Casellas, F, Fontanet, G, Borruel, N, Malagelada, J R

    “…an item to consider in analyzing a healthcare model for a population group suffering from chronic disease is necessary health-care resources, their use, and…”
    Get full text
    Journal Article
  8. 8

    Role of microecology in chronic inflammatory bowel diseases by Guarner, F, Casellas, F, Borruel, N, Antolín, M, Videla, S, Vilaseca, J, Malagelada, J-R

    Published in European journal of clinical nutrition (01-12-2002)
    “…Inflammatory bowel diseases (IBD) are chronic conditions of unknown etiology. Current therapy mitigates the severity of acute bouts of mucosal inflammation but…”
    Get full text
    Journal Article
  9. 9

    Antiinflammatory effects of enterically coated amoxicillin-clavulanic acid in active ulcerative colitis by Casellas, F, Borruel, N, Papo, M, Guarner, F, Antolín, M, Videla, S, Malagelada, J R

    Published in Inflammatory bowel diseases (01-02-1998)
    “…The inflammatory activity of colonic mucosal lesions may be stimulated by intraluminal bacteria. Our aim was to investigate whether administration of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Helicobacter pylori eradication prevents recurrence from peptic ulcer haemorrhage by Vergara, M, Casellas, F, Saperas, E, de Torres, I, Lopez, J, Borruel, N, Armengol, J R, Malagelada, J R

    “…Successful eradication of Helicobacter pylori infection clearly modifies the natural history of peptic ulcer disease and prevents further recurrences of…”
    Get more information
    Journal Article
  12. 12

    P668 Dashboard-guided anti-TNF induction as an effective proactive strategy in Inflammatory Bowel Disease's treatment by Céspedes Martínez, E, Robles-Alonso, V, Herrera-De Guise, C, Mayorga, L, Serra, X, Pérez, Z, Oller, E, Larrosa, M, García-García, S, Casellas, F, Borruel, N

    Published in Journal of Crohn's and colitis (24-01-2024)
    “…Abstract Background Infliximab (IFX) and Adalimumab (ADA) are effective treatments for managing Inflammatory Bowel Disease (IBD) but treatment failure is…”
    Get full text
    Journal Article
  13. 13

    P658 Comparative Efficacy and Safety of Upadacitinib Versus Tofacitinib as Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: A Matching-Adjusted Indirect Comparison by Reinisch, W, Tran, J, Patel, K, Borruel, N, Melmed, G Y, Wegrzyn, L, Levy, G, Ilo, D, Sanchez Gonzalez, Y, Panaccione, R

    Published in Journal of Crohn's and colitis (30-01-2023)
    “…Abstract Background Upadacitinib (UPA) and tofacitinib (TOFA) are Janus kinase (JAK) inhibitors approved for the treatment of patients (pts) with moderately to…”
    Get full text
    Journal Article
  14. 14
  15. 15

    P883 Impaired long-term quantitative cellular response to SARS-COV-2 vaccine in thiopurine-treated IBD patients by Mayorga Ayala, L F, Herrera-deGuise, C, Esperalba, J, Martinez-Gomez, X, Céspedes Martinez, E, Serra Ruiz, X, Robles, V, Lastiri, E, Perez, Z, Oller, E, Fernandez-Naval, C, Martinez-Gallo, M, Casellas, F, Borruel, N

    Published in Journal of Crohn's and colitis (24-01-2024)
    “…Abstract Background SARS-CoV-2 mRNA vaccine induces a robust immune response in most patients with inflammatory bowel disease (IBD). However, humoral…”
    Get full text
    Journal Article
  16. 16

    P322 Effectiveness of Tumor Necrosis Factor-alpha inhibitors and Thiopurines combination therapy according to, 6-thioguanine nucleotides plasma levels: A Systematic Review by Céspedes Martínez, E, Robles, V, Miarons, M, Herrera-De Guise, C, Mayorga-Ayala, L, Perez, Z, Oller, E, Casellas, F, Borruel, N

    Published in Journal of Crohn's and colitis (21-01-2022)
    “…Abstract Background Inflammatory bowel diseases (IBD), Crohn’s disease (CD) and Ulcerative Colitis (CU), have a progressive course with a significant…”
    Get full text
    Journal Article
  17. 17

    The impact of delaying gastric emptying by either meal substrate or drug on the [ C]-urea breath test by Casellas, F, Lopez, J, Borruel, N, Saperas, E, Vergara, M, de Torres, I, Armengol, J R, Malagelada, J-R

    Published in The American journal of gastroenterology (01-02-1999)
    “…Optimal [13C]-urea breath test (UBT) conditions for diagnosis ofHelicobacter pyloriinfection are still being fine-tuned. In the present study we investigated…”
    Get full text
    Journal Article
  18. 18

    P677 Fungal abundance is related to inflammatory status in Ulcerative Colitis by Herrera De Guise, C M, Sarrabayrouse, G, Varela, E, Robles, V, Borruel, N, Mayorga, L F, Casellas, F, Ibarz, A, Perez, Z, Robles, M, Guarner, F

    Published in Journal of Crohn's and colitis (27-05-2021)
    “…Abstract Background Fungi account for approximately 0.1% of the total microorganisms in the gut. Despite the vast body of literature on the bacterial component…”
    Get full text
    Journal Article
  19. 19

    P216 Impact of disease knowledge on quality of life of inflammatory bowel disease patients by Casellas, F, Navarro, E, Herrera-deGuise, C, Robles, V, Borruel, N

    Published in Journal of Crohn's and colitis (25-01-2019)
    “…Abstract Background Inflammatory bowel disease (IBD) impairs patients’ quality of life (QoL). Several factors are involved in the impact of QoL, being the most…”
    Get full text
    Journal Article
  20. 20